Cantarona, Rolando Y.
HRN: 27-17-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/28/2025
06/04/2025
IV
4.5gm
Q6h
SEPSIS
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: